TPTX » Topics » (5) Operating Segments

This excerpt taken from the TPTX 10-Q filed Nov 9, 2006.

(5) Operating Segments

          Beginning March 1, 2005, the OXIS segment reflects our share of OXIS losses under the equity method. Prior to that date, we were organized into two reportable segments: Axonyx and OXIS.

          The following table presents information about our two operating segments for the quarter and nine months ended September 30, 2005:

7



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

OXIS

 

 

 

 

 

 

Axonyx Inc.

 

Int’l Inc.

 

Total

 

 

 


 


 


 

 

 


 

 

 

 

 

Quarter ended September 30, 2005

 

 

 

 

 

 

 

 

 

 

Segment Loss

 

$

(5,579,000

)

$

(108,000

)

$

(5,687,000

)

 

 

 

 

 

 

 

 

 

 

 

Nine months ended September 30, 2005

 

 

 

 

 

 

 

 

 

 

Revenue including minority interest

 

 

 

 

$

403,000

 

$

403,000

 

Segment loss

 

$

(23,865,000

)

$

(434,000

)

$

(24,299,000

)

This excerpt taken from the TPTX 10-Q filed Aug 8, 2006.

(5) Operating Segments

                Beginning March 1, 2005, the OXIS segment reflects the Company’s share of OXIS losses under the equity method. Prior to that date, the Company was organized into two reportable segments: Axonyx and OXIS.

                The following table presents information about the Company’s two operating segments for the quarter and six months ended June 30, 2005:

 
  Axonyx Inc.   OXIS
Int’l Inc.
  Total  
 
 
 
 
Quarter ended June 30, 2005                  
Segment Loss $ (8,050,000 ) $ (129,000 ) $ (8,179,000 )
                   
Six months ended June 30, 2005                  
Revenue including minority interest       $ 403,000   $ 403,000  
Segment loss $ (18,286,000 ) $ (326,000 ) $ (18,612,000 )
 
This excerpt taken from the TPTX 10-Q filed May 10, 2006.

(5) Operating Segments

Beginning March 1, 2005, the OXIS segment reflects the Company’s share of OXIS losses under the equity method. Prior to that date, the Company was organized into two reportable segments: Axonyx and OXIS.

 

The following table presents information about the Company’s two operating segments for the quarter ended March 31, 2005:

 

 

Axonyx Inc.

 

OXIS
Int’l Inc.

 

Total

 

 

 

 

 

 

 

 

 

 

 

 

Quarter ended March 31, 2005

 

 

 

 

 

 

 

 

 

 

Revenue including minority interest

 

 

 

 

$

403,000

 

$

403,000

 

Segment loss

 

$

(10,233,000

)

 

(200,000

)

 

(10,433,000

)

 

 

 

 

 

 

 

 

 

 

 

This excerpt taken from the TPTX 10-Q filed May 10, 2005.

(5)   Operating Segments

                The Company is organized into two reportable segments: Axonyx and OXIS. While OXIS has historically been organized into two reportable segments (health products and therapeutic development), Oxis currently manages its operations in one segment in order to better monitor and manage its basic business: the development of research diagnostics, nutraceutical and therapeutic products.

 
The following table presents information about the Company’s two operating segments:
 
Axonyx Inc. Oxis
Int’l Inc.
Total



Quarter ended March 31, 2005              
Revenue including minority interest         $ 403,000   $ 403,000  
Segment loss   $ (10,233,000 ) $ (200,000 ) $ (10,433,000 )
                     
Quarter ended March 31, 2004                    
Revenue including minority interest         $ 478,000   $ 478,000  
Segment loss   $ (5,704,000 )   (287,000 ) $ (5,991,000 )
                     
Segment assets at December 31, 2004   $ 85,991,000   $ 15,403,000   $ 101,394,000  
 

"(5) Operating Segments" elsewhere:

SurModics (SRDX)
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki